mCMX110 is an orally active SARS-CoV-2 main protease inhibitor with an IC 50 of 35 nM. mCMX110 inhibits SARS-CoV-2 infection . SARS-CoV-2 mCMX110 can be used for the research of SARS-CoV-2 infection .
Products | Products > Disease Areas > Infection | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Virus Protease
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.